SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-022849
Filing Date
2020-05-07
Accepted
2020-05-07 16:09:28
Documents
9
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-8k_20200507.htm 8-K 29070
2 EX-99.1 sndx-ex991_6.htm EX-99.1 203541
3 GRAPHIC gdkaifwlqegg000007.jpg GRAPHIC 2883
4 GRAPHIC gdkaifwlqegg000005.jpg GRAPHIC 2883
5 GRAPHIC gdkaifwlqegg000004.jpg GRAPHIC 2883
6 GRAPHIC gdkaifwlqegg000001.jpg GRAPHIC 2883
7 GRAPHIC gdkaifwlqegg000002.jpg GRAPHIC 2883
8 GRAPHIC gdkaifwlqegg000003.jpg GRAPHIC 2883
9 GRAPHIC gdkaifwlqegg000006.jpg GRAPHIC 2883
  Complete submission text file 0001564590-20-022849.txt   262646
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 20856406
SIC: 2834 Pharmaceutical Preparations